Trending Today ...
police lights
No suspects in Bullhead fatal stabbing

BULLHEAD CITY, Ariz. – Authorities have released the

Community dinners fills up the hungry with holiday

LAKE HAVASU CITY, Ariz. –  Lake Havasu is

gavel
Miller gets four years for BHC drug charges

BULLHEAD CITY, Ariz. – A drug seizure in

police lights
Kingman teen killed UTV crash on Veteran’s Day

KINGMAN, Ariz. – A Kingman teenager was killed

KPOA 18th Annual Thanksgiving Turkey Trot

KINGMAN, Ariz. – The Kingman Police Officers Association

Santa
Breakfast with Santa in Kingman

KINGMAN, Ariz. – Kingman Parks & Recreation will

Thank you for reading The Standard newspaper online!

LBRW dinner set

LAKE HAVASU CITY – London Bridge Republican Women will host their monthly dinner January 4, 2021 at Shugrue’s Bridgeview Room. 5:30 check-in/6:30 dinner . $20.00 check/cash at the door. Guest speaker Mayor Cal Sheehy. Reservations by noon Friday January 1, 2021. RSVP Amie Boggs@ 928-231-6805

Read More

Biasiucci, Cobb eye legislative session

Dist. 5 State Representatives Regina Cobb and Leo Biasiucci discussed their priorities for the upcoming Arizona legislative session during a Dec. 14 zoom tele-conference with Kingman City officials. Cobb said sorting through Governor Doug Ducey’s COVID-19 executive orders will be handled early when the session is convened Jan. 11. “What do we want to extend and what don’t we want to extend,” said Cobb, a Kingman republican. “I think that’s going to be one of our top priorities coming into session.” Biasiucci, a republican from Lake Havasu City, said lawmakers have essentially been sidelined for months during the pandemic that…

Read More

KRMC begins monoclonal antibody therapy for COVID-19 treatment

KINGMAN – Kingman Regional Medical Center (KRMC) has begun using monoclonal antibodies to treat high-risk COVID-19 patients. Monoclonal antibodies are proteins made in a laboratory to mimic the body’s natural immune response. With this treatment, a patient receives an intravenous (IV) infusion of the antibodies. This can enhance the patient’s ability to fight the virus that causes COVID-19. In November, The US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for certain monoclonal antibody therapies. This authorization allows the therapy for COVID-positive patients with high risk for disease progression or hospitalization. Clinical trials suggest that the therapy…

Read More